NCT05556616 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05556616
Title	A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
Acronym	iinnovate-2
Recruitment	Terminated
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Takeda
Indications	multiple myeloma
Therapies	Lenalidomide + TAK-573 Pomalidomide + TAK-573 Bortezomib + TAK-573 Carfilzomib + TAK-573 Bortezomib + Pomalidomide + TAK-573 Carfilzomib + Pomalidomide + TAK-573 Carfilzomib + Daratumumab + TAK-573 Daratumumab + Pomalidomide + TAK-573
Age Groups:	adult \| senior
Covered Countries	USA \| ISR \| ESP \| BEL

NCT05556616
Clinical Trial Detail